文献速递骨肌技术与安全CT

骨盆低剂量CT随访检查——显著剂量降低与锡滤过的影响:体模研究及首次系统性回顾患者分析

Low-Dose CT Imaging of the Pelvis in Follow-up Examinations-Significant Dose Reduction and Impact of Tin Filtration: Evaluation by Phantom Studies and First Systematic Retrospective Patient Analyses.
PubMed 文献 · Invest Radiol · 2022-06-30

本研究通过体模和回顾性患者分析评估骨盆低剂量CT随访成像,重点探讨锡滤过技术对正常及肥胖患者(含或不含金属植入物)的影响。体模中锡滤过低剂量方案在剂量降低67%时图像质量与常规剂量相当;临床随访中剂量可降低达90%而不影响临床评估,金属植入物致图像轻度受损但不影响可评估性,肥胖患者从锡滤过中获益尤著。

要点

  • 骨盆随访CT采用锡滤过低剂量方案可实现90%剂量降低,临床可评估性不受损。
  • 金属植入物会轻度降低锡滤过低剂量与常规剂量CT的图像质量,但不影响可评估性。
  • 肥胖患者从锡滤过低剂量成像中获益更明显,图像噪声与CNR改善(P≤0.05)。

核心结论

  • 锡滤过低剂量CT可在维持特定临床目的(如随访检查、金属植入物位置、材料松动及愈合控制)所需高图像质量的同时实现最大剂量降低,超重患者尤其受益于锡滤过技术;金属植入物虽降低常规剂量与锡滤过低剂量CT的图像质量,但不构成可评估性的相关限制。

研究设计与样本

  • 体模研究测试5种含或不含锡滤过的低剂量与常规剂量CT方案(正常与肥胖体模,迭代重建与滤波反投影重建);随后回顾性患者研究比较45例患者常规剂量CT与随访锡滤过低剂量CT(剂量降低90%),64%患者随访时含金属植入物。

关键影像表现/征象

  • 金属植入物导致锡滤过低剂量与常规剂量CT图像均出现轻度受损。
  • 与常规剂量CT相比,锡滤过低剂量CT中松质骨评估较差(P < 0.001),皮质骨评估相当(P = 0.063)。
  • 锡滤过低剂量方案的品质因数显著更低即更优(P ≤ 0.02)。
  • 肥胖患者在低剂量骨肌成像中从锡滤过获益尤著,表现为图像噪声与CNR改善(P ≤ 0.05)。

诊断标准与关键数值

  • 锡滤过低剂量方案在剂量降低67%时,体模研究中的定性(Likert评分)与定量(图像噪声)分析值与常规剂量方案相等。
  • 临床随访检查中,采用锡滤过低剂量CT扫描剂量可降低达90%,临床研究未显示可评估性受损。
  • 主观评估采用6分Likert评分。

临床应用与阅片要点

  • 骨盆随访CT可考虑采用锡滤过低剂量方案,以实现剂量降低达90%而维持临床可评估性。
  • 评估含金属植入物的低剂量CT图像时,需注意金属植入物可致图像轻度受损,但不影响可评估性。
  • 肥胖患者行低剂量骨肌CT时,锡滤过技术可改善图像噪声与CNR。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Low-dose (LD) computed tomography (CT) is still rarely used in musculoskeletal (MSK) radiology. This study evaluates the potentials of LD CT for follow-up pelvic imaging with special focus on tin filtration (Sn) technology for normal and obese patients with and without metal implants.

MATERIALS AND METHODS: In a phantom study, 5 different LD and normal-dose (ND) CT protocols with and without tin filtration were tested using a normal and an obese phantom. Iterative reconstruction (IR) and filtered back projection (FBP) were used for CT image reconstruction. In a subsequent retrospective patient study, ND CT images of 45 patients were compared with follow-up tin-filtered LD CT images with a 90% dose reduction. Sixty-four percent of patients contained metal implants at the follow-up examination. Computed tomography images were objectively (image noise, contrast-to-noise ratio [CNR], dose-normalized contrast-to-noise ratio [CNRD]) and subjectively, using a 6-point Likert score, evaluated. In addition, the figure of merit was calculated. For group comparisons, paired t tests, Wilcoxon signed rank test, analysis of variance, or Kruskal-Wallis tests were used, where applicable.

RESULTS: The LD Sn protocol with 67% dose reduction resulted in equal values in qualitative (Likert score) and quantitative image analysis (image noise) compared with the ND protocol in the phantom study. For follow-up examinations, dose could be reduced up to 90% by using Sn LD CT scans without impairment in the clinical study. However, metal implants resulted in a mild impairment of Sn LD as well as ND CT images. Cancellous bone ( P < 0.001) was assessed worse and cortical bone ( P = 0.063) equally in Sn LD CT images compared with ND CT images. Figure of merit values were significant ( P ≤ 0.02) lower and hence better in Sn LD as in ND protocols. Obese patients benefited in particular from tin filtration in LD MSK imaging in terms of image noise and CNR ( P ≤ 0.05).

CONCLUSIONS: Low-dose CT scans with tin filtration allow maximum dose reduction while maintaining high image quality for certain clinical purposes, for example, follow-up examinations, especially metal implant position, material loosening, and consolidation controls. Overweight patients benefit particularly from tin filter technology. Although metal implants decrease image quality in ND as well as in Sn LD CT images, this is not a relevant limitation for assessability.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Schüle, Gärtner, Halt, et al. Low-Dose CT Imaging of the Pelvis in Follow-up Examinations-Significant Dose Reduction and Impact of Tin Filtration: Evaluation by Phantom Studies and First Systematic Retrospective Patient Analyses. Invest Radiol. 2022. PMID: 35776429. doi:10.1097/RLI.0000000000000898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。